Dendritic Cell Vaccines for Cancer Immunotherapy: The Role of Human Conventional Type 1 Dendritic Cells

Throughout the last decades, dendritic cell (DC)-based anti-tumor vaccines have proven to be a safe therapeutic approach, although with inconsistent clinical results. The functional limitations of ex vivo monocyte-derived dendritic cells (MoDCs) commonly used in these therapies are one of the pointe...

Descripción completa

Detalles Bibliográficos
Autores principales: Calmeiro, João, Carrascal, Mylène A., Tavares, Adriana Ramos, Ferreira, Daniel Alexandre, Gomes, Célia, Falcão, Amílcar, Cruz, Maria Teresa, Neves, Bruno Miguel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076373/
https://www.ncbi.nlm.nih.gov/pubmed/32075343
http://dx.doi.org/10.3390/pharmaceutics12020158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076373/
https://www.ncbi.nlm.nih.gov/pubmed/32075343
http://dx.doi.org/10.3390/pharmaceutics12020158

Ejemplares similares